U.S. Markets closed

Bristol-Myers Squibb: A Long Idea for Aggressive Traders Only

Bruce Kamich

In the Lightning Round of Wednesday's Mad Money program, Jim Cramer favored Bristol-Myers Squibb Co. which has been in a downtrend from August," Cramer told viewers. In the daily bar chart of BMY, below, we can identify three trends in the past twelve months.